IDSA Leads Support for Robust Federal Public Health and Biomedical Research Workforce (PDF)
IDSA led over 150 groups in a letter to President Trump in support of a robust federal public health and biomedical research workforce.
IDSA Statement on WHO Priority Antibiotic-Resistant Pathogen List
The Infectious Diseases Society of America welcomes today’s announcement from the World Health Organization of its “priority pathogens” list to guide and promote antibiotic research and development. We call upon United States policy makers and international leaders to commit the resources necessary to realize the goals of this list.
IDSA Highlights Pressing ID Policy Issues for New HHS Secretary (PDF)
IDSA outlines a number of pressing ID policy priorities for new HHS Secretary Dr. Tom Price, including antimicrobial resistance, domestic and global public health programs, infrastructure, and preparedness, biomedical research and innovation, and ID physician workforce issues.
IDSA Releases Core Principles for Antibacterial Drug Pathway (PDF)
IDSA and other groups outline a proposed new law to create a limited population antibacterial drug (LPAD) pathway.
IDSA Statement on Executive Order on Immigrant and Refugee Travel to U.S.
Infectious diseases do not respect national borders, and success in fighting them requires a global response. Broad international collaboration is critical to our ability to identify, track and respond to emerging infectious diseases.
IDSA Statement on Vaccines
The Infectious Diseases Society of America (IDSA) stands behind the overwhelming scientific evidence that has repeatedly demonstrated the overall safety and benefit of routine childhood vaccinations. Children are far more likely to be harmed by vaccine preventable illness, such as measles, than by the vaccines that prevent such infections.
Oxytetracycline Use in Agriculture Raises Concerns (PDF)
IDSA called for an end to the authorized use of the antibiotic on fruit orchards, pending more research.
IDSA Outlines ID Policy Issues for Trump Transition Team (PDF)
IDSA outlines important ID policy issues for Vice President-elect Mike Pence, head of the Trump Transition Team.
1 of 8
New FDA Drug Safety Communication on chlorhexidine gluconate - Drug Information Update
FDA Drug Safety Communication on chlorhexidine gluconate- Drug Information
FDA MedWatch - ED-3490TK Video Duodenoscope by Pentax: FDA Safety Communication - UPDATE
FDA MedWatch - Duodenoscopes by Fujifilm Medical Systems: Safety Communication - Certain Older Models Removed From Clinical Use
CDC Updates Guidance for Pregnant Women and Women and Men of Reproductive Age for Zika Virus Infection
The U.S. Centers for Disease Control and Prevention (CDC) previously issued travel, testing, and other guidance related to areas of active Zika virus transmission in Florida.
CDC Advises Hospitals to Alert Patients at Risk from Contaminated Heater-Cooler Devices Used during Cardiac Surgery
The Centers for Disease Control and Prevention (CDC) is advising hospitals to notify patients who underwent open-heart (open-chest) surgery involving a Stöckert 3T heater-cooler that the device was potentially contaminated, possibly putting patients at risk for a life threatening infection.
Zika Virus Infection Related to the Ongoing Investigation of Local Mosquito-borne Zika Virus Transmission in Miami-Dade County, Florida
FDA issues final rule on safety and effectiveness of antibacterial soaps
FDA Advises Testing for Zika Virus in All Donated Blood in the US
Read More >>
A team approach is vital to the successful diagnosis and treatment of complex neurological infections related to placement of devices in the brain, or as a result of neurosurgery or head trauma. This is among the recommendations in the first comprehensive guidelines on healthcare-associated ventriculitis and meningitis, which are being released by the Infectious Diseases Society of America (IDSA) and published in the journal Clinical Infectious Diseases.
>> Read More
Nonsteroidal anti-inflammatory drugs and respiratory infections may have a combined effect on heart attack risk, a JID study suggests.
From the PresidentApply for FIDSA by April 3New 2017 Society AwardsIn Memoriam: Leon G. Smith, MD, FIDSAJournal Club
The 2017 Infectious Diseases fellowship match brought some good news to the ID community.
Patients at risk for latent or active tuberculosis (TB) infection should be assessed with newer tests, including interferon-gamma release assays (IGRAs) and molecular diagnostics, recommend guidelines on TB diagnosis developed by the American Thoracic Society (ATS), Infectious Diseases Society of America (IDSA) and Centers for Disease Control and Prevention (CDC) and published in the journal Clinical Infectious Diseases.
The Infectious Diseases Society of America (IDSA) applauds the Senate for passing the 21st Century Cures Act earlier today.
From the PresidentABIM's MOC ProgramIDSA and HIVMA Society AwardsIDWeek 2016 Recap
1 of 7
1300 Wilson Boulevard Suite 300 Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2017 Infectious Diseases Society of America